Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Synergistic Anti-Tumor Efficacy of BET Inhibitors JQ1 and Otx-015 in Combination with Dasatinib in Preclinical Models of T-Cell Lymphomas

Sara Rizzitano, Alessandra Cavanè, Marco Piazzoni, Antonio Vendramin, Silvia Gimondi, Giulia Biancon, Sofia Cannara Malan, Anna Dodero, Paolo Corradini, Cristiana Carniti

Blood (2016) 128 (22): 3967.

https://doi.org/10.1182/blood.V128.22.3967.3967

Published: 2016

Journal Articles

Disease Monitoring in Multiple Myeloma Patients Using Liquid Biopsy and Next Generation Sequencing of IGH Gene Rearrangements

Silvia Gimondi, Giulia Biancon, Antonio Vendramin, Silvia Zaninelli, Sara Rizzitano, Sofia Cannara Malan, Anisa Bermema, Vittorio Montefusco, Cristiana Carniti, Paolo Corradini

Blood (2016) 128 (22): 4430.

https://doi.org/10.1182/blood.V128.22.4430.4430

Published: 2016

Journal Articles

Genomic Landscape and Its Prognostic Implications in Multiple Myeloma Using a Targeted Sequencing Approach

Niccolo Bolli, MD PhD, Hervé Avet-Loiseau, MD, Silvia Gimondi, Yilong Li, Vijitha Sathiaseelan, Adam Samuel Sperling, MD PhD, Kenneth C Anderson, MD, Stephane Minvielle, Peter J Campbell, MD PhD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 370.

https://doi.org/10.1182/blood.V126.23.370.370

Published: 2015

Journal Articles

Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients

Silvia Gimondi, Alessandra Cavanè, Antonio Vendramin, Biancon Giulia, Anisa Bermema, Vittorio Montefusco, Paolo Corradini, Cristiana Carniti

Blood (2015) 126 (23): 2987.

https://doi.org/10.1182/blood.V126.23.2987.2987

Published: 2015

Journal Articles

a Novel Method for the Detection of Minimal Residual Disease in B-Cell Malignancies: Ion Semiconductor Sequencing for the Evaluation of Igh Gene Rearrangements

Silvia Gimondi, Alessandra Cavanè, Antonio Vendramin, Giulia Biancon, Paolo Corradini, MD, Cristiana Carniti

Blood (2014) 124 (21): 2983.

https://doi.org/10.1182/blood.V124.21.2983.2983

Published: 2014

Journal Articles

Pharmacologic Inhibition of JAK1/JAK2 Signaling Protects from Acute GvHD While Preserving Gvt in Mice

Cristiana Carniti, Silvia Gimondi, Antonio Vendramin, Camilla Recordati, DVM, PhD Dipl. ECVP, Davide Confalonieri, Anisa Bermema, Paolo Corradini, MD, Jacopo Mariotti, MD

Blood (2014) 124 (21): 1107.

https://doi.org/10.1182/blood.V124.21.1107.1107

Published: 2014

Journal Articles

In Vivo Jak1/Jak2 Inhibition Protects From Acute GvHD While Maintaining Robust Anti-Tumor Activity

Cristiana Carniti, Silvia Gimondi, Antonio Vendramin, Davide Confalonieri, Camilla Recordati, DVM, PhD, Dipl. ECVP, Anisa Bermema, Jacopo Mariotti, Paolo Corradini

Blood (2013) 122 (21): 4481.

https://doi.org/10.1182/blood.V122.21.4481.4481

Published: 2013

Journal Articles

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

Cristiana Carniti, PhD, Silvia Gimondi, Raffaella Vaccaroli, Antonio Vendramin, PhD, Anisa Bermema, Enrico Radaelli, DVM, PhD, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 2997.

https://doi.org/10.1182/blood.V120.21.2997.2997

Published: 2012

Journal Articles

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

Cristiana Carniti, PhD, Antonio Vendramin, PhD, Silvia Gimondi, Anisa Bermema, Fabiana Riva, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 1898.

https://doi.org/10.1182/blood.V120.21.1898.1898

Published: 2012

Journal Articles

High-Dose Rituximab in the Conditioning Regimen Before Allogeneic Stem Cell Transplantation Reduces the Incidence of Acute Gvhd in B-Cell Lymphomas

Paolo Corradini, Barbara Sarina, MD, Cristiana Carniti, PhD, Francesca Patriarca, MD, Angelo Michele Carella, MD, Alessandro Levis, Alberto Bosi, MD, Michele Falda, Paolo Di Bartolomeo, MD, Cecilia Olivares, MD, Silvia Gimondi, Antonio Vendramin, Anna Dodero, MD

Blood (2011) 118 (21): 4546.

https://doi.org/10.1182/blood.V118.21.4546.4546

Published: 2011

Journal Articles

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

Cristiana Carniti, PhD, Silvia Gimondi, Davide Lucini, Jacopo Mariotti, MD, Anisa Bermema, Antonio Vendramin, Mara Morelli, MD, Chiara Formica, Paolo Corradini, MD

Blood (2011) 118 (21): 311.

https://doi.org/10.1182/blood.V118.21.311.311

Published: 2011

NARROW

Synergistic Anti-Tumor Efficacy of BET Inhibitors JQ1 and Otx-015 in Combination with Dasatinib in Preclinical Models of T-Cell Lymphomas

Disease Monitoring in Multiple Myeloma Patients Using Liquid Biopsy and Next Generation Sequencing of IGH Gene Rearrangements

Genomic Landscape and Its Prognostic Implications in Multiple Myeloma Using a Targeted Sequencing Approach

Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients

a Novel Method for the Detection of Minimal Residual Disease in B-Cell Malignancies: Ion Semiconductor Sequencing for the Evaluation of Igh Gene Rearrangements

Pharmacologic Inhibition of JAK1/JAK2 Signaling Protects from Acute GvHD While Preserving Gvt in Mice

In Vivo Jak1/Jak2 Inhibition Protects From Acute GvHD While Maintaining Robust Anti-Tumor Activity

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

High-Dose Rituximab in the Conditioning Regimen Before Allogeneic Stem Cell Transplantation Reduces the Incidence of Acute Gvhd in B-Cell Lymphomas

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only